Stock Scorecard
Stock Summary for Apyx Medical Corp (APYX) - $1.45 as of 4/26/2024 6:04:27 PM EST
Total Score
9 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for APYX
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for APYX
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for APYX
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 |
Bonus Criteria for APYX
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for APYX
Financial Details for APYX
Company Overview |
|
---|---|
Ticker | APYX |
Company Name | Apyx Medical Corp |
Country | USA |
Description | Apyx Medical Corporation, an energy technology company, develops, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. The company is headquartered in Clearwater, Florida. |
Sector Name | LIFE SCIENCES |
Industry Name | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
Most Recent Quarter | 12/31/2023 |
Next Earnings Date | 5/9/2024 |
Stock Price History |
|
Last Day Price | 1.45 |
Last Day Price Updated | 4/26/2024 6:04:27 PM EST |
Last Day Volume | 58,368 |
Average Daily Volume | 220,044 |
52-Week High | 7.97 |
52-Week Low | 1.21 |
Last Price to 52 Week Low | 19.83% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 48.42 |
Sector PE | 56.64 |
5-Year Average PE | -10.31 |
Free Cash Flow Ratio | 1.15 |
Industry Free Cash Flow Ratio | 60.10 |
Sector Free Cash Flow Ratio | 30.65 |
Current Ratio Most Recent Quarter | 5.52 |
Total Cash Per Share | 1.26 |
Book Value Per Share Most Recent Quarter | 0.77 |
Price to Book Ratio | 1.84 |
Industry Price to Book Ratio | 5.21 |
Sector Price to Book Ratio | 22.15 |
Price to Sales Ratio Twelve Trailing Months | 0.97 |
Industry Price to Sales Ratio Twelve Trailing Months | 14.23 |
Sector Price to Sales Ratio Twelve Trailing Months | 5.17 |
Share Statistics |
|
Total Shares Outstanding | 34,643,900 |
Market Capitalization | 50,233,655 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Dividend Aristocrat? | False |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 1.94% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 0.00% |
Annual Earnings Growth | 19.28% |
Reported EPS 12 Trailing Months | -0.54 |
Reported EPS Past Year | 0.00 |
Reported EPS Prior Year | -0.62 |
Net Income Twelve Trailing Months | -18,713,000 |
Net Income Past Year | -18,713,000 |
Net Income Prior Year | -23,184,000 |
Quarterly Revenue Growth YOY | 16.30% |
5-Year Revenue Growth | 23.91% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 43,700,000 |
Total Cash Past Year | 43,700,000 |
Total Cash Prior Year | 10,200,000 |
Net Cash Position Most Recent Quarter | -31,300,000 |
Net Cash Position Past Year | -31,300,000 |
Long Term Debt Past Year | 75,000,000 |
Long Term Debt Prior Year | 0 |
Total Debt Most Recent Quarter | 75,000,000 |
Equity to Debt Ratio Past Year | 0.26 |
Equity to Debt Ratio Most Recent Quarter | 0.26 |
Total Stockholder Equity Past Year | 26,701,000 |
Total Stockholder Equity Prior Year | 37,582,000 |
Total Stockholder Equity Most Recent Quarter | 26,701,000 |
Options |
|
Put/Call Ratio | 0.00 |
Has Options | False |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -0.08 |
MACD Signal | -0.11 |
20-Day Bollinger Lower Band | 1.07 |
20-Day Bollinger Middle Band | 2.01 |
20-Day Bollinger Upper Band | 2.95 |
Beta | 1.12 |
RSI | 47.99 |
50-Day SMA | 3.48 |
200-Day SMA | 6.49 |
System |
|
Modified | 4/26/2024 6:04:28 PM EST |